Bitzaron, Israel

Daria Lemann-Blumenthal

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Daria Lemann-Blumenthal: Innovator in Laser Technology

Introduction

Daria Lemann-Blumenthal is a prominent inventor based in Bitzaron, Israel. She has made significant contributions to the field of laser technology, particularly in ophthalmology. With a total of 3 patents, her work focuses on improving treatment methods for eye conditions.

Latest Patents

One of her latest patents is titled "Protection for Direct Selective Laser Trabeculoplasty." This innovative apparatus includes an optical unit with a light source and beam-directing elements. The radiation source is designed to irradiate a patient's eye with treatment beams while ensuring the eye fixates on the light source. The apparatus also features an optical filter that inhibits the passage of treatment beams but allows visible light to pass through. Another notable patent is "Avoiding Blood Vessels During Direct Selective Laser Trabeculoplasty." This system includes a radiation source and a controller that designates multiple target regions on a patient's eye for irradiation. The controller performs an iterative process to ensure that no obstructions are present before the radiation source irradiates the designated locations.

Career Highlights

Daria has worked with notable companies such as Belkin Vision Ltd. and Belkin Laser Ltd. Her experience in these organizations has contributed to her expertise in laser technology and its applications in medical treatments.

Collaborations

Throughout her career, Daria has collaborated with talented individuals, including Zachary Sacks and Arieh Kisos. These partnerships have further enhanced her innovative work in the field.

Conclusion

Daria Lemann-Blumenthal is a trailblazer in the realm of laser technology for ophthalmology. Her patents reflect her commitment to advancing medical treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…